4//SEC Filing
VERTEX PHARMACEUTICALS INC / MA 4
Accession 0001209191-17-038895
$VRTXCIK 0000875320operating
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:31 PM ET
Size
8.2 KB
Accession
0001209191-17-038895
Insider Transaction Report
Form 4
BOGER JOSHUA S
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock
2017-06-08+2,941→ 284,088 total - Exercise/Conversion
Deferred Stock Units
2017-06-08−2,941→ 0 total→ Common Stock (2,941 underlying)
Holdings
- 13,286(indirect: By 401(k))
Common Stock
- 64,525(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Each deferred stock unit represents one share of common stock and converted into common stock upon the termination of Dr. Boger's service on our board of directors on 06/08/2017.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000875320
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:31 PM ET
- Size
- 8.2 KB